See also this year's filing and all EDGAR filings for this company.
PDF Report 0001447028_2023_Arbutus_Biopharma_Corp.pdf
Logs
Graph
Absolute values for 0001447028, Arbutus Biopharma Corp
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 151,139,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 5,070,000 |
| 3 | remainder_Assets | 39,210,000 |
| 4 | LiabilitiesCurrent | 32,857,000 |
| 5 | LiabilitiesNoncurrent | 1,815,000 |
| 6 | remainder_Liabilities | 23,895,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 17,834,000 |
| 9 | ResearchAndDevelopmentExpense | 84,408,000 |
| 10 | remainder_Expenses | 6,677,000 |
| 11 | remainder_Revenues | 39,019,000 |
| 12 | remainder_NetIncome | 444,000 |
| 13 | remainder_ComprehensiveNetIncome | -2,153,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 195,419,000 |
| 1 | Liabilities | 58,567,000 |
| 2 | Expenses | 108,919,000 |
| 3 | Revenues | 39,019,000 |
| 4 | StockholdersEquity | 136,852,000 |
| 5 | NetIncome | -69,456,000 |
| 6 | ComprehensiveNetIncome | -70,532,500 |
| 7 | BaseVar | 202,260,500 |
| 8 | EconomicCapitalRatio | 1.30 |